國藥科技(08156.HK)訂立口罩原料合同 料年底前生產逾3億個口罩
國藥科技(08156.HK)公布,子公司分別向中石油分公司及天津泰達訂立產品銷售合同,採購聚丙烯熔噴法非織造布。已簽訂的產品銷售合同包括未來五個月內按公司生產需求及實際採購單數量向中石油分公司及天津泰達採購熔噴布,預計採購計劃為337噸,後續採購訂單將可在此基礎上增加。依照計劃採購量,截至今年底,可用於生產超過3億個口罩。
公司表示,其中兩條生產線獲批「本地口罩生產資助計劃」申請,與香港政府訂立為期一年的採購合同,將於一年內提供最多4,800萬個口罩。除香港政府外,公司與醫院管理局及社會福利署等香港政府機構建立供銷關係,亦建立起廣泛的企業及零售客戶群。網絡自營商店上線亦拓寬銷售渠道,拉近生產端與銷售段的距離。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.